Correlation Between Merrimack Pharmaceuticals and Cullinan Oncology
Can any of the company-specific risk be diversified away by investing in both Merrimack Pharmaceuticals and Cullinan Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merrimack Pharmaceuticals and Cullinan Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merrimack Pharmaceuticals and Cullinan Oncology LLC, you can compare the effects of market volatilities on Merrimack Pharmaceuticals and Cullinan Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merrimack Pharmaceuticals with a short position of Cullinan Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merrimack Pharmaceuticals and Cullinan Oncology.
Diversification Opportunities for Merrimack Pharmaceuticals and Cullinan Oncology
0.55 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Merrimack and Cullinan is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Merrimack Pharmaceuticals and Cullinan Oncology LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cullinan Oncology LLC and Merrimack Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merrimack Pharmaceuticals are associated (or correlated) with Cullinan Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cullinan Oncology LLC has no effect on the direction of Merrimack Pharmaceuticals i.e., Merrimack Pharmaceuticals and Cullinan Oncology go up and down completely randomly.
Pair Corralation between Merrimack Pharmaceuticals and Cullinan Oncology
If you would invest 1,196 in Merrimack Pharmaceuticals on August 28, 2024 and sell it today you would earn a total of 0.00 from holding Merrimack Pharmaceuticals or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 4.55% |
| Values | Daily Returns |
Merrimack Pharmaceuticals vs. Cullinan Oncology LLC
Performance |
| Timeline |
| Merrimack Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Cullinan Oncology LLC |
Merrimack Pharmaceuticals and Cullinan Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Merrimack Pharmaceuticals and Cullinan Oncology
The main advantage of trading using opposite Merrimack Pharmaceuticals and Cullinan Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merrimack Pharmaceuticals position performs unexpectedly, Cullinan Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cullinan Oncology will offset losses from the drop in Cullinan Oncology's long position.| Merrimack Pharmaceuticals vs. Amicus Therapeutics | Merrimack Pharmaceuticals vs. Celldex Therapeutics | Merrimack Pharmaceuticals vs. Puma Biotechnology | Merrimack Pharmaceuticals vs. Agios Pharm |
| Cullinan Oncology vs. Eliem Therapeutics | Cullinan Oncology vs. Scpharmaceuticals | Cullinan Oncology vs. Milestone Pharmaceuticals | Cullinan Oncology vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |